Approval · Notice of Compliance 3831 · 1997
COPAXONE: Notice of Compliance 3831
Issued September 4, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3831
- Date
- September 4, 1997
- Company
- Teva Pharmaceuticals Usa
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Immunomodulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COPAXONE | 02233014 | Cancelled Post Market |
Medicinal ingredients
- GLATIRAMER ACETATE 20 MG per VIAL